Published: October 02, 2009
Z-Medica QuikClot Hemostatic Gauze Effective and Safe in Controlling Bleeding Following Adenotonsillectomy
SAN DIEGO - (BUSINESS WIRE) - Data from a recent study of Z-Medica's QuikClot hemostatic gauze
demonstrated QuikClot to be a safe and effective way to achieve
hemostasis in pediatric patients undergoing adenotonsillectomy. The data
will be presented by Dr. Estela Chavez Delgado, PI for the study during
the annual meeting of the American Academy of Otolaryngology - Head and
Neck Surgery (AAO-HNSF) on Monday, October 5, 2009 between 11:00 a.m.
and 11:28 a.m. PT.
The purpose of the study was to evaluate the safety and efficacy of
QuikClot kaolin-based hemostatic dressings in 123 pediatric patients
undergoing adenotonsillectomy. The study found that the use of the
hemostatic gauze resulted in excellent outcomes. With the application of
QuikClot hemostatic gauze, the average time to bleeding control was
108+/-61 seconds and complete hemostasis was achieved within five
minutes in 83 percent of cases (vs. 27% when standard surgical technique
was used pâ¹0.001). Additionally, a greater proportion of patients
treated with QuikClot had slight or absent throat pain 18 hours
following surgery and minimal peritonsillectomy inflammation was found
in 69.4 percent of patients in the study group. Children treated with
QuikClot were able to start liquid diet significantly sooner than
controls and required significantly less pain control medications.
"We are pleased that the initial study findings indicate that QuikClot
is safe and effective for use following pediatric adenotonsillectomy,"
said Dr. Giacomo Basadonna, chief medical officer, Z-Medica. "As we
identify possible new uses within the hospital environment, our team of
medical professionals is developing QuikClot hemostatic gauze products
best suited for various new external applications."
About Z-Medica
Z-Medica Corporation is a medical device company developing innovative
and cost-effective hemostatic agents. The company manufactures and
markets its QuikClot family of products for hemostasis for use by
health care professionals, first responders, law enforcement officers
and the military. QuikClot products rapidly enhance the body's natural
coagulation process, helping to achieve hemostasis faster. Z-Medica's
QuikClot Combat Gauze product was chosen by the Committee on Tactical
Combat Casualty Care (TCCC) as the United States Military's sole source
supplier for first-line hemostatic treatment, based on tests conducted
by the Naval Medical Research Center and the U.S. Army Institute for
Surgical Research. QuikClot products are also widely used by first
responders, in hospital emergency rooms, interventional cardiology and
radiology laboratories and other healthcare environments where bleeding
requires fast and effective control. Z-Medica, named one of the Top 100
Technology "Companies to Watch" in 2008 by the Connecticut Technology
Council, is a privately-held company based in Wallingford, CT.
For Z-Medica
James McCusker, 203-858-2143
James.McCusker@icrinc.com
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News